Abstract
Altered sialylation has been implicated in malignant properties of cancer cells. However, the detailed molecular mechanism remains uncertain. Our studies on mammalian sialidases have facilitated understanding of the molecular bases of aberrant sialylation related to malignancy. Among four types of sialidase so far identified in mammalian cells and tissues, the plasma membrane-associated sialidase NEU3, acting preferentially on gangliosides, has been found to be markedly upregulated in various human carcinomas, and involved in promotion of malignant phenotypes including cell migration, invasiveness and cell survival. NEU3 regulates various signaling pathways critical to cellular homeostasis, and its marked increase in cancer causes dysregulation of the physiological processes resulting in enhancement of tumor initiation, promotion, and progression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480
Hakomori SI (2010) Glycosynaptic, microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett 584:1901–1906
Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T (2002) Up-regulation of plasma membrane-associated gangliosidesialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci U S A 99:10718–10723
Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, Miyazaki K, Saijo S, Miyagi T (2006) Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling. Biochem J 394:647–656
Kawamura S, Sato I, Wada T, Yamaguchi K, Li Y, Li D, Zhao X, Ueno S, Aoki H, Tochigi T, Kuwahara M, Kitamura T, Takahashi K, Moriya S, Miyagi T (2012) Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling. Cell Death Differ 19:170–179
Lau KS, Dennis JW (2008) N-Glycans in cancer progression. Glycobiology 18:750–760
Miyagi T, Yamaguchi K (2012) Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 22:880–896
Miyagi T, Sagawa J, Kuroki T, Matsuya Y, Tsuiki S (1990) Tumor-promoting phorbol ester induces alterations of sialidase and sialyltransferase activities of JB6 cells. Jpn J Cancer Res 81:1286–1292
Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, Tokuyama S, Sawada M (1999) Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem 274:5004–5011
Miyagi T, Wada T, Yamaguchi K, Hata K, Shiozaki K (2008) Plasma membrane-associated sialidase as a crucial regulator of transmembrane signaling. J Biochem 144:279–285
Miyagi T, Takahashi K, Hata K, Shiozaki K, Yamaguchi K (2012) Sialidase significance for cancer progression. Glycoconj J 29:567–577
Phelps RA, Chidester S, Dehghanizadeh S, Phelps J, Sandoval IT, Rai K, Broadbent T, Sarkar S, Burt RW, Jones DA (2009) A two step model for colon adenoma initiation and progression caused by APC loss. Cell 137:623–634
Schengrund CL, Lausch RN, Rosenberg A (1973) Sialidase activity in transformed cells. J Biol Chem 248:4424–4428
Shiozaki K, Yamaguchi K, Sato I, Miyagi T (2009) Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice. Cancer Sci 100:588–594
Ueno S, Saito S, Wada T, Yamaguchi K, Satoh M, Arai Y, Miyagi T (2006) Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem 281:7756–7764
Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T (2007) A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene 26:2483–2490
Wierstra I (2008) Sp1: emerging roles–beyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun 372:1–13
Yamaguchi K, Koseki K, Shiozaki M, Shimada Y, Wada T, Miyagi T (2010) Regulation of plasma-membrane-associated sialidase NEU3 gene by Sp1/ Sp3 transcription factors. Biochem J 430:107–117
Yamaguchi K, Shiozaki K, Moriya S, Koseki K, Wada T, Tateno H, Sato I, Asano M, Iwakura Y, Miyagi T (2012) Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase. PLoS One 7:e41132
Yamanami H, Shiozaki K, Wada T, Yamaguchi K, Uemura T, Kakugawa Y, Hujiya T, Miyagi T (2007) Down-regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers. Cancer Sci 98:299–307
Yogeeswaran G, Hakomori S (1975) Cell contact-dependent ganglioside changes in mouse 3T3 fibroblasts and a suppressed sialidase activity on cell contact. Biochemistry 14:2151–2156
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Miyagi, T., Takahashi, K., Shiozaki, K., Yamaguchi, K., Hosono, M. (2015). Plasma Membrane-Associated Sialidase Confers Cancer Initiation, Promotion and Progression. In: Chakrabarti, A., Surolia, A. (eds) Biochemical Roles of Eukaryotic Cell Surface Macromolecules. Advances in Experimental Medicine and Biology, vol 842. Springer, Cham. https://doi.org/10.1007/978-3-319-11280-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-11280-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11279-4
Online ISBN: 978-3-319-11280-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)